Bipolar Clinical Trials

4 recruiting

Bipolar Trials at a Glance

191 actively recruiting trials for bipolar are listed on ClinicalTrialsFinder across 6 cities in 44 countries. The largest study group is Not Applicable with 91 trials, with the heaviest enrollment activity in Houston, Atlanta, and Miami. Lead sponsors running bipolar studies include VA Office of Research and Development, Massachusetts General Hospital, and Centre for Addiction and Mental Health.

Treatments under study

About Bipolar Clinical Trials

Looking for clinical trials for Bipolar? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Bipolar trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Bipolar clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 191 trials

Recruiting

NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder

MigraineMajor DepressionBipolar Disorder
National Institute of Mental Health (NIMH)1,260 enrolled1 locationNCT05669703
Recruiting
Phase 3

A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine

Bipolar DisorderMania
Bristol-Myers Squibb424 enrolled103 locationsNCT07140913
Recruiting
Phase 2

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder

Bipolar 1 Disorder
Rapport Therapeutics Inc.224 enrolled22 locationsNCT07046494
Recruiting
Phase 2

A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)

Bipolar Disorder
Eli Lilly and Company400 enrolled88 locationsNCT07286175
Recruiting
Phase 3

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

Bipolar Disorder Type I With Mania or Mania With Mixed Features
Bristol-Myers Squibb274 enrolled74 locationsNCT06951711
Recruiting
Not Applicable

SYNCED - SYNChronized Eating in Bipolar Depression Study

Bipolar I DisorderBipolar II DisorderBipolar Depression
University of Ottawa40 enrolled1 locationNCT06560957
Recruiting
Phase 1Phase 2

Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine

SchizophreniaMajor Depressive DisorderBipolar I Disorder
Mapi Pharma Ltd.24 enrolled6 locationsNCT07185815
Recruiting

Biomarker Research on Ultra-High-Field MRI Combined With Visual Perception Assessment in the Diagnosis and Treatment Outcomes of Severe Mental Disorders

SchizophreniaMajor Depressive Disorder (MDD)Bipolar Disorder+1 more
Second Affiliated Hospital, School of Medicine, Zhejiang University320 enrolled1 locationNCT07479758
Recruiting

Identifying Cerebral Hemodynamic Patterns in Mood Disorders and Mild Cognitive Impairment: A Functional Near-Infrared Spectroscopy (fNIRS) Study

Major Depressive DisorderBipolar DisorderMild Cognitive Impairment
Mayo Clinic200 enrolled1 locationNCT06897670
Recruiting
Phase 3

A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

Bipolar Disorder Type I With Mania
Bristol-Myers Squibb450 enrolled170 locationsNCT06929273
Recruiting
Not Applicable

A Study of Home-use Brain Stimulation to Treat Bipolar Depression

Bipolar Disorder (BD)
King's College London212 enrolled1 locationNCT07556692
Recruiting

mHealth Estimate-based Algorithms Signaling Upcoming Recurrence of Episodes in Bipolar Disorders

Bipolar Disorder
VA Office of Research and Development200 enrolled1 locationNCT06204705
Recruiting
Not Applicable

Child Bipolar Network Ketogenic Diet Approach to Bipolar Disorder in Adolescents

AdolescentsBipolar Disorder (BD)Bipolar Disorder I or II+2 more
University of California, Los Angeles80 enrolled4 locationsNCT06920940
Recruiting
Phase 1Phase 2

A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Subjects With Bipolar I Disorder

Bipolar I Disorder
Alzamend Neuro, Inc.20 enrolled1 locationNCT07540338
Recruiting
Phase 2

Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.

Bipolar I Disorder
LB Pharmaceuticals Inc.320 enrolled3 locationsNCT07494305
Recruiting
Not Applicable

Decoding Emotional Dynamics in Bipolar Disorder

Healthy (Controls)Bipolar Disorder I or II
Laureate Institute for Brain Research, Inc.72 enrolled1 locationNCT07221864
Recruiting
Phase 4

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

SchizophreniaMajor Depressive DisorderBipolar Disorder+2 more
Neurocrine Biosciences50 enrolled19 locationsNCT07105111
Recruiting
Phase 3

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder

Bipolar-I Disorder With Mania or Mania With Mixed Features
Bristol-Myers Squibb274 enrolled63 locationsNCT06951698
Recruiting
Not Applicable

Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder

Bipolar DisorderBipolar Disorder Type 1
Stony Brook University100 enrolled3 locationsNCT06373016
Recruiting
Phase 2

A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

Bipolar I DisorderBipolar II Disorder
AbbVie195 enrolled29 locationsNCT06696755